{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:26:01Z","timestamp":1783733161254,"version":"3.55.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disorder marked by motor impairments such as stiffness, involuntary shaking, and slowed movement. In addition, PD patients frequently experience nonmotor symptoms, especially depression. This study uses a mixed-methods scientometric analysis to review global research trends and advancements in PD and depression. This analysis is vital for clinicians, researchers, and policymakers, identifying knowledge gaps and directing future research efforts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a comprehensive literature review on PD and depression using the Web of Science database from 2004 to 2023, facilitated by CiteSpace 6.1.R6. Our analysis examined collaborations among authors, institutions, countries, and keywords, incorporating insights from RCTs and qualitative studies. We calculated effect sizes and confidence intervals with precision. Ethical approval was not required as the study used publicly available data without personal information.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Our analysis included 3048 research papers and 915 reviews, involving 17,927 authors and 12,466 institutions. The United States and the University of Toronto led in publications. Studies revealed significant effect sizes with narrow confidence intervals, particularly on the prevalence and impact of depression in PD patients. High-frequency keywords included \u201cParkinson\u2019s disease,\u201d \u201cdepression,\u201d \u201cquality of life,\u201d \u201cnon-motor symptom,\u201d and \u201cdementia.\u201d Visual mapping identified critical research nodes and future directions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Over the past 2 decades, research on the PD-depression link has accelerated. Our analysis highlights prevailing trends and critical areas, providing evidence-based recommendations for therapeutic strategies. This study offers valuable insights for clinicians and researchers, emphasizing future research priorities to improve patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041537","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:01:07Z","timestamp":1739818867000},"page":"e41537","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Progress and prospects of Parkinson\u2019s disease with depression research: A global bibliometric analysis based on CiteSpace"],"prefix":"10.1097","volume":"104","author":[{"given":"Jianlin","family":"Li","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhang","family":"You","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaipu","family":"Li","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University, Jining, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The People\u2019s Hospital of Rizhao, Rizhao, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8584-2894","authenticated-orcid":false,"given":"Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, China"},{"name":"Department of Neurology, The People\u2019s Hospital of Rizhao, Rizhao, Shandong Province, China"},{"name":"Department of Central Laboratory, Shandong Provincial Key Medical and Health Laboratory of Perioperative Precise Anesthesia and Organ Protection Mechanism Research, Rizhao Key Laboratory of Basic Research on Anesthesia and Respiratory Intensive Care, The People\u2019s Hospital of Rizhao, Rizhao, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1982-8970","authenticated-orcid":false,"given":"Tao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Shandong Provincial Key Medical and Health Laboratory of Perioperative Precise Anesthesia and Organ Protection Mechanism Research, Rizhao Key Laboratory of Basic Research on Anesthesia and Respiratory Intensive Care, The People\u2019s Hospital of Rizhao, Rizhao, Shandong Province, China"},{"name":"School of Anesthesiology, Shandong Second Medical University, Weifang, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250217","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease.","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R2-20250217","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-212922","article-title":"Preventing Parkinson\u2019s disease: an environmental agenda.","volume":"12","author":"De Miranda","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R3-20250217","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuro.2021.11.011","article-title":"Role of melatonin in TLR4-mediated inflammatory pathway in the MPTP-induced mouse model.","volume":"88","author":"Yildirim","year":"2022","journal-title":"Neurotoxicology"},{"key":"R4-20250217","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/hsc.13055","article-title":"Letting nature take its course: a qualitative exploration of the illness and adjustment experiences of Hong Kong Chinese people with Parkinson\u2019s disease.","volume":"28","author":"Kwok","year":"2020","journal-title":"Health Soc Care Community"},{"key":"R5-20250217","doi-asserted-by":"crossref","first-page":"101840","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies.","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R6-20250217","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acn3.51022","article-title":"Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.","volume":"7","author":"Weintraub","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"R7-20250217","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/08919887211018267","article-title":"Mood disorders and anxiety in Parkinson\u2019s disease: current concepts.","volume":"34","author":"Lintel","year":"2021","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R8-20250217","doi-asserted-by":"crossref","first-page":"74","DOI":"10.31083\/j.jin2103074","article-title":"Relationship between apathy and subjective poor night-time sleep in de novo, untreated Parkinson\u2019s disease.","volume":"21","author":"Hong","year":"2022","journal-title":"J Integr Neurosci"},{"key":"R9-20250217","doi-asserted-by":"crossref","first-page":"307","DOI":"10.31083\/j.jin2002030","article-title":"Behavioral characterization in MPTP\/p mouse model of Parkinson\u2019s disease.","volume":"20","author":"Wada","year":"2021","journal-title":"J Integr Neurosci"},{"key":"R10-20250217","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/ijms25063219","article-title":"Peripheral upregulation of Parkinson\u2019s disease-associated genes encoding \u03b1-synuclein, \u03b2-glucocerebrosidase, and ceramide glucosyltransferase in major depression.","volume":"25","author":"Brazdis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R12-20250217","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/hmg\/ddac081","article-title":"Phenome-wide screening of the putative causal determinants of depression using genetic data.","volume":"31","author":"Aman","year":"2022","journal-title":"Hum Mol Genet"},{"key":"R13-20250217","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.23528","article-title":"Symptomatology and markers of anxiety disorders in Parkinson\u2019s disease: a cross-sectional study.","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov Disord"},{"key":"R14-20250217","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3233\/JPD-213093","article-title":"Patient-related factors influencing caregiver burden in Parkinson\u2019s disease patients: comparison of effects before and after deep brain stimulation.","volume":"12","author":"Van Hienen","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R15-20250217","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JPD-230176","article-title":"Investigating the shared genetic etiology between Parkinson\u2019s disease and depression.","volume":"14","author":"Reyes-P\u00e9rez","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"R16-20250217","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2147\/NDT.S403002","article-title":"Parkinson\u2019s disease related depression and anxiety: a 22-year bibliometric analysis (2000-2022).","volume":"19","author":"Zhang","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R17-20250217","doi-asserted-by":"crossref","first-page":"742311","DOI":"10.3389\/frma.2021.742311","article-title":"Exploring topics in bibliometric research through citation networks and semantic analysis.","volume":"6","author":"Mejia","year":"2021","journal-title":"Front Res Metr Anal"},{"key":"R18-20250217","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"Van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R19-20250217","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization.","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20250217","first-page":"1","article-title":"Science mapping: a systematic review of the literature.","volume":"2","author":"Chen","year":"2017","journal-title":"J Data Inf Sci"},{"key":"R21-20250217","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature.","volume":"57","author":"Chen","year":"2006","journal-title":"J Assoc Inf Sci Technol"},{"key":"R22-20250217","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.joi.2018.03.005","article-title":"Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools.","volume":"12","author":"Pan","year":"2018","journal-title":"J Informetr"},{"key":"R23-20250217","doi-asserted-by":"crossref","first-page":"e0223994","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews.","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R24-20250217","doi-asserted-by":"crossref","first-page":"759347","DOI":"10.3389\/fpsyg.2021.759347","article-title":"Study on pain catastrophizing from 2010 to 2020: a bibliometric analysis via CiteSpace.","volume":"12","author":"Luo","year":"2021","journal-title":"Front Psychol"},{"key":"R25-20250217","doi-asserted-by":"crossref","first-page":"141293","DOI":"10.1016\/j.chemosphere.2024.141293","article-title":"Trends in phytoremediation of heavy metals-contaminated soils: a Web of science and CiteSpace bibliometric analysis.","volume":"352","author":"Zhang","year":"2024","journal-title":"Chemosphere"},{"key":"R26-20250217","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","article-title":"Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses.","volume":"22","author":"Falagas","year":"2008","journal-title":"FASEB J"},{"key":"R27-20250217","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11192-020-03690-4","article-title":"Google Scholar, Microsoft Academic, Scopus, Dimensions, Web of Science, and OpenCitations\u2019 COCI: a multidisciplinary comparison of coverage via citations.","volume":"126","author":"Mart\u00edn-Mart\u00edn","year":"2021","journal-title":"Scientometrics"},{"key":"R28-20250217","doi-asserted-by":"crossref","first-page":"776883","DOI":"10.3389\/fpsyt.2021.776883","article-title":"Studies on children with developmental coordination disorder in the past 20 years: a bibliometric analysis via CiteSpace.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Psychiatry"},{"key":"R29-20250217","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/asi.21309","article-title":"The structure and dynamics of co-citation clusters: a multiple-perspective co-citation analysis.","volume":"61","author":"Chen","year":"2010","journal-title":"J Am Soc Inf Sci Technol"},{"key":"R30-20250217","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic.","volume":"8","author":"Dorsey","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"R31-20250217","article-title":"Analysis and visualization of citation networks.","author":"Zhao","year":"2015","journal-title":"Anal Vis Cit Netw"},{"key":"R32-20250217","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/aris.1440370106","article-title":"Visualizing knowledge domains.","volume":"37","author":"B\u00f6rner","year":"2003","journal-title":"Annu Rev Inf Sci Technol"},{"key":"R33-20250217","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A","article-title":"How does Parkinson\u2019s disease affect quality of life? A comparison with quality of life in the general population.","volume":"15","author":"Schrag","year":"2000","journal-title":"Mov Disord"},{"key":"R34-20250217","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score.","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"key":"R35-20250217","doi-asserted-by":"crossref","first-page":"47677","DOI":"10.34117\/bjdv.v7i5.29678","article-title":"Doen\u00e7a de Parkinson: revis\u00e3o de literatura\/Parkinson\u2019s disease: literature review.","volume":"7","author":"Silva","year":"2021","journal-title":"Braz J Dev"},{"key":"R36-20250217","doi-asserted-by":"crossref","first-page":"15","DOI":"10.11606\/issn.1981-4690.v35i1p15-24","article-title":"Preditor de qualidade de vida em indiv\u00edduos com doen\u00e7a de Parkinson moderada.","volume":"35","author":"Miliatto","year":"2021","journal-title":"Rev Bras Educ F\u00eds Esporte"},{"key":"R37-20250217","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/erp.11.106","article-title":"Quality of life and burden in caregivers for patients with Parkinson\u2019s disease: concepts, assessment and related factors.","volume":"12","author":"Martinez-Martin","year":"2012","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R38-20250217","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/mds.21567","article-title":"Quality of life and related concepts in Parkinson\u2019s disease: a systematic review.","volume":"22","author":"Den Oudsten","year":"2007","journal-title":"Mov Disord"},{"key":"R39-20250217","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/ane.12760","article-title":"Non-motor symptoms and quality of life in subjects with mild parkinsonian signs.","volume":"136","author":"Prasuhn","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"R40-20250217","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0028-3886.79133","article-title":"Relationship of depression, disability, and quality of life in Parkinson\u2019s disease: a hospital-based case-control study.","volume":"59","author":"Arun","year":"2011","journal-title":"Neurol India"},{"key":"R41-20250217","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art.","volume":"84","author":"Leite Silva","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R42-20250217","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years.","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"R43-20250217","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"R44-20250217","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson\u2019s disease: current understanding of its neurobiology and implications for treatment.","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"key":"R45-20250217","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11065-004-8158-5","article-title":"Quality of life of caregivers.","volume":"14","author":"Glozman","year":"2004","journal-title":"Neuropsychol Rev"},{"key":"R46-20250217","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"R47-20250217","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment.","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R48-20250217","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy.","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N Engl J Med"},{"key":"R49-20250217","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","article-title":"Natural history of multiple system atrophy in the USA: a prospective cohort study.","volume":"14","author":"Low","year":"2015","journal-title":"Lancet Neurol"},{"key":"R50-20250217","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"R51-20250217","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy.","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"R52-20250217","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","article-title":"Imaging biomarkers in Parkinson\u2019s disease.","volume":"95","author":"Brooks","year":"2011","journal-title":"Prog Neurobiol"},{"key":"R53-20250217","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [(18)F]FDG: version 2.","volume":"36","author":"Varrone","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R54-20250217","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.eclinm.2022.101589","article-title":"Efficacy of repetitive transcranial magnetic stimulation in Parkinson\u2019s disease: a systematic review and meta-analysis of randomised controlled trials.","volume":"52","author":"Zhang","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R55-20250217","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","article-title":"Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).","volume":"125","author":"Lefaucheur","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"R56-20250217","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17425255.2017.1273901","article-title":"Use of monoamine oxidase inhibitors in chronic neurodegeneration.","volume":"13","author":"Riederer","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R57-20250217","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","article-title":"Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.","volume":"125","author":"Shih","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"R58-20250217","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","article-title":"Monoamine oxidase inactivation: from pathophysiology to therapeutics.","volume":"60","author":"Bortolato","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"R59-20250217","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543776.2018.1427735","article-title":"MAO inhibitors and their wider applications: a patent review.","volume":"28","author":"Carradori","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"R60-20250217","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1517\/14656566.2015.1086748","article-title":"Rasagiline for the treatment of Parkinson\u2019s disease: an update.","volume":"16","author":"Stocchi","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"R61-20250217","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0091270005277935","article-title":"Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease.","volume":"45","author":"Chen","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R62-20250217","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ncl.2008.05.002","article-title":"Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.","volume":"26","author":"Bainbridge","year":"2008","journal-title":"Neurol Clin"},{"key":"R63-20250217","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future.","volume":"12","author":"Tan","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"R64-20250217","doi-asserted-by":"crossref","first-page":"204512532098599","DOI":"10.1177\/2045125320985993","article-title":"The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson\u2019s disease: meta-analysis of randomized controlled trials.","volume":"11","author":"Huang","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"R65-20250217","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease.","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"R66-20250217","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/bs11050074","article-title":"Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors.","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"R67-20250217","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/bs11040054","article-title":"Treatment of Parkinson\u2019s disease with cognitive impairment: current approaches and future directions.","volume":"11","author":"Sun","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"R68-20250217","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease.","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regener Res"},{"key":"R69-20250217","doi-asserted-by":"crossref","first-page":"1278323","DOI":"10.3389\/fnagi.2023.1278323","article-title":"Research progress of ferroptosis in Parkinson\u2019s disease: a bibliometric and visual analysis.","volume":"15","author":"Lu","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"R70-20250217","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12964-023-01346-3","article-title":"Autophagy-modulating biomaterials: multifunctional weapons to promote tissue regeneration.","volume":"22","author":"Wu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"R71-20250217","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","article-title":"Compensatory mechanisms in Parkinson\u2019s disease: circuits adaptations and role in disease modification.","volume":"298","author":"Blesa","year":"2017","journal-title":"Exp Neurol"},{"key":"R72-20250217","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res Rev"},{"key":"R73-20250217","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3389\/fpsyg.2018.01647","article-title":"Evolving concepts of emotion and motivation.","volume":"9","author":"Berridge","year":"2018","journal-title":"Front Psychol"},{"key":"R74-20250217","doi-asserted-by":"crossref","first-page":"958022","DOI":"10.3389\/fphar.2022.958022","article-title":"Interleukin 22 and its association with neurodegenerative disease activity.","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"R75-20250217","doi-asserted-by":"crossref","first-page":"597491","DOI":"10.3389\/fnagi.2020.597491","article-title":"Visual abnormalities associate with hippocampus in mild cognitive impairment and early Alzheimer\u2019s disease.","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"R77-20250217","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/traumacare2040042","article-title":"Traumatic brain injury and secondary neurodegenerative disease.","volume":"2","author":"Dodd","year":"2022","journal-title":"Trauma Care"},{"key":"R78-20250217","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1017\/cts.2023.537","article-title":"Recent innovations in adaptive trial designs: a review of design opportunities in translational research.","volume":"7","author":"Kaizer","year":"2023","journal-title":"J Clin Transl Sci"},{"key":"R79-20250217","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12967-022-03765-1","article-title":"Integration of CRISPR\/Cas9 with artificial intelligence for improved cancer therapeutics.","volume":"20","author":"Bhat","year":"2022","journal-title":"J Transl Med"},{"key":"R80-20250217","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nm.2224","article-title":"The benefits and limitations of animal models for translational research in neurodegenerative diseases.","volume":"16","author":"Jucker","year":"2010","journal-title":"Nat Med"},{"key":"R81-20250217","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nhtm.2014.08.001","article-title":"Animal models in translational medicine: validation and prediction.","volume":"2","author":"Denayer","year":"2014","journal-title":"Eur J Mol Clin Med"},{"key":"R82-20250217","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability.","volume":"8","author":"Blesa","year":"2014","journal-title":"Front Neuroanat"},{"key":"R83-20250217","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11192-015-1765-5","article-title":"The journal coverage of Web of Science and Scopus: a comparative analysis.","volume":"106","author":"Mongeon","year":"2016","journal-title":"Scientometrics"},{"key":"R84-20250217","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1609\/icwsm.v3i1.13937","article-title":"Gephi: an open source software for exploring and manipulating networks.","volume":"3","author":"Bastian","year":"2009","journal-title":"Proc Int AAAI Conf Web Soc Media"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:01:26Z","timestamp":1739818886000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041537","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}